FindTrial
Sign In

A case control study to compare prevalence of liver fibrosis in patients with Acanthosis and Non Acanthosis.

A Case control study to compare prevalence of liver fibrosis in patients with Acanthosis Nigricans and without Acanthosis Nigricans.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/06/054229
Enrollment
300
Registered
2023-06-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with T2DM (up to 15 years Duration) 2. Age 25 to 60 years 3. BMI >25 kg/m² to >40 kg/m² 4. Gender- Both (Male & Female) 5. Mild, Moderate and Severe acanthosis nigricans (Photograph)

Exclusion criteria

Exclusion criteria: 1. Chronic Alcoholic with Moderate to Severe. 2. BMI >40 kg/m² 3. Congestive heart disease 4. Positive hepatitis B or hepatitis C, secondary causes of fatty liver (eg. consumption of amiodarone and tamoxifen) and congestive hepatopathy. 5. Severe end organ damage or chronic diseases: renal/hepatic failure, any malignancy, major systemic illness etc.

Design outcomes

Primary

MeasureTime frame
To Compare prevalence of liver fibrosis in patients with acanthosis nigricans and without acanthosis nigricans subjects.Timepoint: 12 MONTHS—

Secondary

MeasureTime frame
To determine the association between acanthosis nigricans and liver fibrosis.Timepoint: 12 MONTHS—

Countries

India

Contacts

Public ContactDr ANOOP MISRA

Fortis CDOC Hospital

anoopmisra@gmail.com01149101222

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026